ETR vs FDMT · P/E 28, rev $12.95B vs rev $37.0K
Entergy Corporation (ETR) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the ETR and FDMT stock pages for the full models.
Not investment advice.